Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | Leading pharmaceuticals gather to discuss the latest developments in ADCsSMi's Antibody Drug Conjugate masterclass, taking place on the 2 December in London, will provide comprehensive insights into CMC issues during the development, with a particular focus on the assessment and control of the quality of such products.
By: smi group (Source: John M Lambert, Drug-conjugated antibodies for the treatment of cancer (http://onlinelibrary.wiley.com/ SMi's masterclass hosted by PAREXEL International will discuss ADCs which are being clinically tested in a range of oncology indications. In the absence of specific guidance on the development of ADCs, this workshop aims to help participants understand the CMC issues during the development, with a particular focus on the assessment and control of the quality of such products. Benefits of Attending • Identify key parameters for non-clinical studies to support a Phase 1 clinical trial • Consider the factors that influence the choice of conjugate and linker types • Learn how to create an early phase product development plan that meets regulatory expectations • Network with and learn from senior industry representatives To view the full conference programme, visit www.smi-online.co.uk/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|